Tumour sensitivity to cytembena in women with metastasizing gynaecological carcinoma in relation to certain inherited blood characters and serum isoenzymes.
D000179:Acrylates / Q000627:therapeutic use*; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001565:Benzoates / Q000627:therapeutic use; D001789:Blood Group Antigens; D001966:Bromine / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D005838:Genotype; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010670:Phenylthiourea; D013649:Taste; D014594:Uterine Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000179:Acrylates; D000970:Antineoplastic Agents; D001565:Benzoates; D001789:Blood Group Antigens; D007527:Isoenzymes; D010670:Phenylthiourea; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001966:Bromine